Rezuena, Baby Boy .
HRN: 21-72-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
AMPICILLIN 500MG (VIAL)
08/15/2022
08/22/2022
IV
170mg
Q12hours
T/c Neonatal Pneumonia; PSNB Sec To Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes